Theravance Biopharma, Inc.TBPHNASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Over Time
Trending higher, above historical average, modest growth trend.
Left:
||||
Revenue minus cost of goods sold
Latest
$64.38M
↑ 182% above average
Average (9y)
$22.83M
Historical baseline
Range
High:$73.41M
Low:$-138.35M
CAGR
+6.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $64.38M | +283.2% |
| 2023 | $16.80M | +239.5% |
| 2022 | $-12.05M | +91.3% |
| 2021 | $-138.35M | -292.5% |
| 2020 | $71.86M | -2.1% |
| 2019 | $73.41M | +23.1% |
| 2018 | $59.66M | +537.6% |
| 2017 | $9.36M | -79.6% |
| 2016 | $45.75M | +22.1% |
| 2015 | $37.47M | - |